✦ LIBER ✦

Which subgroup of patients with pathologic N2 non-small cell lung cancer benefit from surgery?

✍ Scribed by Yasunobu Funakoshi, Yukiyasu Takeuchi, Hidenori Kusumoto, Toru Kimura, Hajime Maeda

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Examining the benefits of chemotherapy i

✍ Billingham, L.J; Cullen, M.H 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 140 KB

Induction Chemotherapy with Cisplatin, V

✍ Shinji Akamine; Yoichi Nakamura; Tadayuki Oka; Hiroshi Soda; Hideki Taniguchi; M 📂 Article 📅 2008 🏛 CIG Media Group, LP. 🌐 English ⚖ 138 KB

Postoperative Radiotherapy for Patients

✍ Mantovani, Cristina; Giaj Levra, Niccolo; Filippi, Andrea R.; Novello, Silvia; B 📂 Article 📅 2013 🏛 CIG Media Group, LP. 🌐 English ⚖ 475 KB

Clinical Outcomes of Thoracoscopic Lobec

✍ Zhong, Chenxi; Yao, Feng; Zhao, Heng 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 497 KB

Survival of Patients With True Pathologi

✍ Robert J. Cerfolio; Ayesha S. Bryant 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 419 KB

Prognostic factors in patients with N2 n

✍ Saito, M; Nakamura, H; Hiyoshi, T; Ohira, T; Nomura, M; Tsuboi, M; Ikeda, N; Kaw 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 110 KB